- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FCS Advancing Therapies for Patients Through Clinical Research in Community Oncology Practices
Florida Cancer Specialists & Research Institute provides the newest cancer therapies, some not yet available elsewhere, through convenient access to clinical trials.
The survival rate for Americans diagnosed with several of the most common cancers has increased dramatically in the past nearly 3 decades, thanks in large part to scientific discoveries and treatment advances. Florida Cancer Specialists & Research Institute (FCS) physicians and patients are part of these leading-edge cancer innovations, providing the newest cancer therapies, some not yet available elsewhere, through convenient access to clinical trials.
This is possible through FCS' long-standing partnership with Sarah Cannon—a trusted expert in the field of oncology research having conducted more than 500 first-in-human trials and been a clinical trial leader in the majority of approved cancer therapies over the last decade.
Since the inception of our research program, 10,000 patients have participated in innovative studies.
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
